Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TXNRD1 | Q16881 | 6/20 | 0.43 |
| ▸ | TXNRD3 | Q86VQ6 | 6/20 | 0.43 |
| ▸ | TXNRD2 | Q9NNW7 | 6/20 | 0.43 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alfadex SCHEMBL2229587 | 0.88 | ALDH1A1 (0.53) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL193191 | 0.88 | ALDH1A1 (0.53) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL306328 | 0.86 | ALDH1A1 (0.51) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL21629653 | 0.82 | ALDH1A1 (0.47) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL23198883 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| SCHEMBL30767995 | 0.78 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| SCHEMBL29352258 | 0.77 | ALDH1A1 (0.59) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| SCHEMBL29401827 | 0.75 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL23198880 | 0.74 | ALDH1A1 (0.59) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Alfadex SCHEMBL25413932 | 0.74 | ALDH1A1 (0.80) | ALDH1A1TSHRLMNATDP1TXNRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113271923-B | Pharmaceutical composition of furosemide and application thereof | SQ创新股份公司 | 2025-05-13 | — | — | CN | claimed |
| CN-118121544-B | Phloretin-liposome composition based on molecular inclusion compound and preparation method and application thereof | 合肥和晨生物科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118121560-B | Phloretin composite microcapsule based on molecular inclusion compound and preparation method and application thereof | 合肥和晨生物科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118217292-A | Triple compound pharmaceutical composition for treating glaucoma | 苏州裕泰医药科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118141947-A | Phloretin-hydrophilic active ingredient dual-embedding delivery preparation based on molecular inclusion compound and preparation method and application thereof | 上海交通大学 | 2024-06-07 | — | — | CN | claimed |
| CN-118121560-A | Phloretin composite microcapsule based on molecular inclusion compound and preparation method and application thereof | 合肥和晨生物科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-118121544-A | Phloretin-liposome composition based on molecular inclusion compound and preparation method and application thereof | 合肥和晨生物科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-117757100-A | Preparation method of cyclodextrin modified polysaccharide-based supermolecular polymer | 南开大学 | 2024-03-26 | — | — | CN | claimed |
| CN-116920123-A | Toremifene cyclodextrin inclusion and preparation method thereof | 重庆士立德医药科技有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116617413-A | Eutectic solvent, preparation method thereof and transdermal drug delivery system matrix | 季华实验室 | 2023-08-22 | — | — | CN | claimed |
| CN-116407510-A | Sublingual tablet of butylphthalide and preparation method thereof | 河北赛谱睿思医药科技有限公司 | 2023-07-11 | — | — | CN | claimed |
| EP-4121037-A1 | INHALATIONAL THERAPY FOR COVID-19 | Memorial Sloan Kettering Cancer Center (US) | 2023-01-25 | — | — | EP | claimed |
| CN-113189159-B | Electrochemical sensor for simultaneously detecting nitrophenol isomers and preparation method thereof | 天津科技大学（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-115068410-A | Triptolide clathrate temperature-change gel for articular cavity injection and preparation method thereof | 重庆医药高等专科学校 | 2022-09-20 | — | — | CN | claimed |
| EP-3946268-A1 | INHALED STATINS AS BRONCHODILATORS TO IMPROVE LUNG FUNCTION IN RESPIRATORY DISEASES | The Regents of The University of California (US) | 2022-02-09 | — | — | EP | claimed |
| WO-2025124498-A1 | LIPOSOME OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | 上海艾力斯医药科技股份有限公司 | 2025-06-19 | — | — | WO | disclosed |
| WO-2025119195-A1 | COMBINATION OF POLQ INHIBITOR AND ANTI-CANCER THERAPEUTIC AGENT | DANATLAS PHARMACEUTICALS CO., LTD. (CN) | 2025-06-12 | — | — | WO | disclosed |
| CN-114585364-A | Use of glutamate 2b receptor antagonists and sigma receptor agonists as antitussives | 阿尔杰农制药股份有限公司 | 2022-06-03 | — | — | CN | disclosed |
| WO-2022066835-A1 | SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) | 2022-03-31 | — | — | WO | disclosed |
| CN-111040015-B | 19-nor-C21 substituted steroid derivatives | 南京诺瑞特医药科技有限公司 | 2022-03-18 | — | — | CN | disclosed |